Literature DB >> 6770028

The functional relationship of the interleukins.

K A Smith, L B Lachman, J J Oppenheim, M F Favata.   

Abstract

The mechanism of the lymphoproliferative effect of the macrophage product lymphocyte-activating factor [LAF(IL1] appears to be mediated by the stimulation of the release of T cell growth factor [TCGF(IL2)] by T cells. The magnitude of the resultant T cell proliferative clonal expansion is thus dependent upon the quantity of both LAF(IL1) and TCGF(IL2) induced by antigen or lectin stimulation. These observations, coupled with the ability to measure the production and actions of these hormone-like lymphokines, should allow for increased insight into the mode of action of immunoenhancing and immunosuppressive agents, as well as for new therapeutic approaches to disease states involving T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6770028      PMCID: PMC2185867          DOI: 10.1084/jem.151.6.1551

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

3.  Partial purification of human lymphocyte-activating factor (LAF) by ultrafiltration and electrophoretic techniques.

Authors:  L B Lachman; M P Hacker; R E Handschumacher
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

Review 4.  Glucocorticoids and immune responses.

Authors:  G R Crabtree; S Gillis; K A Smith; A Munck
Journal:  Arthritis Rheum       Date:  1979-11

5.  Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines.

Authors:  L B Lachman; M P Hacker; G T Blyden; R E Handschumacher
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

6.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells.

Authors:  M S Meltzer; J J Oppenheim
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes.

Authors:  S Gillis; N A Union; P E Baker; K A Smith
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

  8 in total
  150 in total

1.  Pyrimidinone (bropirimine) mediated alteration of T lymphocyte subsets during murine cytomegalovirus infection.

Authors:  R J Brideau; J A Nicholas
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

2.  Biological activity of sea bass (Dicentrarchus labrax L.) recombinant interleukin-1beta.

Authors:  Francesco Buonocore; Maria Forlenza; Elisa Randelli; Stefania Benedetti; Paola Bossù; Sabrina Meloni; Christopher J Secombes; Massimo Mazzini; Giuseppe Scapigliati
Journal:  Mar Biotechnol (NY)       Date:  2005-07-21       Impact factor: 3.619

3.  Unique properties of auranofin as a potential anti-rheumatic drug.

Authors:  M L Barrett; G P Lewis
Journal:  Agents Actions       Date:  1986-10

4.  Defective interleukin-1 production in a familial monocyte disorder with a combined abnormality of mobility and phagocytosis-killing.

Authors:  A Komiyama; M Ichikawa; H Kanda; K Aoyama; K Yasui; M Yamazaki; H Kawai; Y Miyagawa; T Akabane
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

5.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

Authors:  R B Kimble; J L Vannice; D C Bloedow; R C Thompson; W Hopfer; V T Kung; C Brownfield; R Pacifici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Role of individual chains of HLA-DR antigens in activation of T cells induced by alloantigens.

Authors:  R Palacios
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

7.  Anterior pituitary hormone control by interleukin 2.

Authors:  S Karanth; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells.

Authors:  R Pacifici; A Carano; S A Santoro; L Rifas; J J Jeffrey; J D Malone; R McCracken; L V Avioli
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 9.  Cytokines and T-Cell Homeostasis in HIV Infection.

Authors:  Michael L Freeman; Carey L Shive; Thao P Nguyen; Souheil-Antoine Younes; Soumya Panigrahi; Michael M Lederman
Journal:  J Infect Dis       Date:  2016-10-01       Impact factor: 5.226

10.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.